Prestige Consumer Healthcare (NYSE:PBH) Hits New 12-Month High – What’s Next?

Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) hit a new 52-week high on Thursday . The company traded as high as $84.21 and last traded at $84.21, with a volume of 29579 shares changing hands. The stock had previously closed at $82.67.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on PBH. Jefferies Financial Group reissued a “hold” rating and set a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reiterated a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. One analyst has rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $83.67.

Prestige Consumer Healthcare Trading Up 1.8 %

The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $4.16 billion, a price-to-earnings ratio of 20.47, a P/E/G ratio of 2.32 and a beta of 0.47. The firm’s 50-day moving average is $73.91 and its 200 day moving average is $70.48.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.09. The business had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The company’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.07 EPS. On average, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Mary Beth Fritz sold 9,885 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $81.97, for a total transaction of $810,273.45. Following the sale, the senior vice president now directly owns 18,835 shares in the company, valued at approximately $1,543,904.95. This represents a 34.42 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider William P’pool sold 8,987 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total transaction of $735,585.95. Following the sale, the insider now directly owns 20,058 shares in the company, valued at $1,641,747.30. The trade was a 30.94 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 38,810 shares of company stock valued at $3,187,300. Company insiders own 1.60% of the company’s stock.

Institutional Trading of Prestige Consumer Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in PBH. Coldstream Capital Management Inc. bought a new position in shares of Prestige Consumer Healthcare in the third quarter valued at approximately $205,000. Geode Capital Management LLC boosted its holdings in Prestige Consumer Healthcare by 4.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock valued at $95,678,000 after purchasing an additional 50,961 shares during the period. M&T Bank Corp increased its holdings in shares of Prestige Consumer Healthcare by 23.8% in the third quarter. M&T Bank Corp now owns 4,594 shares of the company’s stock worth $331,000 after purchasing an additional 882 shares during the period. Barclays PLC raised its position in shares of Prestige Consumer Healthcare by 346.3% in the third quarter. Barclays PLC now owns 92,444 shares of the company’s stock worth $6,665,000 after buying an additional 71,730 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its stake in Prestige Consumer Healthcare by 10.3% during the third quarter. Public Employees Retirement System of Ohio now owns 91,779 shares of the company’s stock valued at $6,617,000 after buying an additional 8,533 shares during the period. 99.95% of the stock is currently owned by institutional investors.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.